• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Extended-release quinolone shows efficacy in complicated UTIs, acutepyelonephritis


Chicago -Once daily dosing with ciprofloxacin extended-release 1,000 mg (CiproXR) is as safe and effective as twice a day administration with conventionalciprofloxacin, 500 mg (Cipro), in the treatment of complicated urinary tractinfections and acute pyelonephritis, according to the results of a NorthAmerican, multicenter study.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.